Cargando…

Intrathecal Trastuzumab Treatment in Patients with Breast Cancer and Leptomeningeal Carcinomatosis

Leptomeningeal carcinomatosis is a fatal manifestation of metastatic breast cancer. Investigation of intrathecal (IT) trastuzumab for leptomeningeal carcinomatosis is currently underway; however, there has been no consensus. We report on two cases of human epidermal growth factor receptor 2 positive...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Won-Young, Kim, Han-Jo, Kim, Kyoungha, Bae, Sang-Byung, Lee, Namsu, Lee, Kyu-Taek, Won, Jong-Ho, Park, Hee-Sook, Lee, Sang-Cheol
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Cancer Association 2016
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4843730/ https://www.ncbi.nlm.nih.gov/pubmed/25761487 http://dx.doi.org/10.4143/crt.2014.234

Ejemplares similares

Recent Advancements of Treatment for Leptomeningeal Carcinomatosis
por: Gwak, Ho-Shin, et al.
Publicado: (2015)

Cerebrospinal fluid metabolomic profiles can discriminate patients with leptomeningeal carcinomatosis from patients at high risk for leptomeningeal metastasis
por: Yoo, Byong Chul, et al.
Publicado: (2017)

Clinical outcome of cerebrospinal fluid shunts in patients with leptomeningeal carcinomatosis
por: Kim, Hye Seon, et al.
Publicado: (2019)

Intrathecal trastuzumab for leptomeningeal carcinomatosis in patients with human epidermal growth factor receptor 2 positive breast cancer
por: Gulia, Seema, et al.
Publicado: (2016)

Diagnostic and prognostic values of cerebrospinal fluid CYFRA 21-1 in patients with leptomeningeal carcinomatosis
por: Hyun, Jae-Won, et al.
Publicado: (2017)

Long-term complete response to intrathecal trastuzumab in a patient with leptomeningeal carcinomatosis due to her2- overexpressing breast cancer: Case report
por: García, Francisco José Valdivia, et al.
Publicado: (2020)

Molecular Targeted Therapies for the Treatment of Leptomeningeal Carcinomatosis: Current Evidence and Future Directions
por: Lee, Dae-Won, et al.
Publicado: (2016)

Effects of Postoperative Radiotherapy on Leptomeningeal Carcinomatosis or Dural Metastasis after Resection of Brain Metastases in Breast Cancer Patients
por: Ha, Boram, et al.
Publicado: (2017)

Chest Wall Pain as the Presenting Symptom of Leptomeningeal Carcinomatosis
por: Sim, Kyoung Bo, et al.
Publicado: (2014)

A case of metastatic leptomeningeal carcinomatosis from early gastric carcinoma
por: Park, Kwang-Kuk, et al.
Publicado: (2012)

HER2+ esophageal carcinoma leptomeningeal metastases treated with intrathecal trastuzumab regimen
por: Wu, Scott A, et al.
Publicado: (2023)

Pulsed Erlotinib as Sole Treatment of Leptomeningeal Carcinomatosis: Can We Avoid the Use of Intrathecal Therapy?
por: Santhosh-Kumar, Cheruppolil R., et al.
Publicado: (2014)

Src Family Kinase Inhibitor PP2 Has Different Effects on All-Trans-Retinoic Acid or Arsenic Trioxide-Induced Differentiation of an Acute Promyelocytic Leukemia Cell Line
por: Yoon, Suk-Gu, et al.
Publicado: (2013)

GnRH Agonist Therapy in a Patient with Recurrent Ovarian Granulosa Cell Tumors
por: Kim, Hyun Jung, et al.
Publicado: (2009)

Leptomeningeal Carcinomatosis of Gastric Cancer Misdiagnosed as Vestibular Schwannoma
por: Kim, Shin-Jae, et al.
Publicado: (2014)

Incidence and Risk Factors for Leptomeningeal Carcinomatosis in Breast Cancer Patients with Parenchymal Brain Metastases
por: Jung, Jong-myung, et al.
Publicado: (2012)

Large Cell Neuroendocrine Carcinoma of the Colon With Carcinomatosis Peritonei
por: Kim, Jang Jin, et al.
Publicado: (2018)

Intrathecal trastuzumab: immunotherapy improves the prognosis of leptomeningeal metastases in HER-2+ breast cancer patient
por: Lu, Nu T., et al.
Publicado: (2015)

SDPS-16 CYTOLOGIC AND SEROLOGIC RESPONSE WITH INTRATHECAL METHOTREXATE IN A PATIENT WITH LEPTOMENINGEAL CARCINOMATOSIS FROM OVARIAN CANCER
por: Cordova, Christine, et al.
Publicado: (2023)

Association Between c-Met and Lymphangiogenic Factors in Patients With Colorectal Cancer
por: Kim, Han Jo, et al.
Publicado: (2018)

Leptomeningeal Carcinomatosis with Delayed Ocular Manifestations
por: Czyz, Craig, et al.
Publicado: (2021)

Leptomeningeal carcinomatosis or ischemic cerebrovascular disease?
por: Eran, Ayelet, et al.
Publicado: (2021)

Pathophysiological Role of Hormones and Cytokines in Cancer Cachexia
por: Kim, Hyun Jung, et al.
Publicado: (2012)

Safety and Effectiveness of Central Venous Catheterization in Patients with Cancer: Prospective Observational Study
por: Kim, Hyun Jung, et al.
Publicado: (2010)

Gemcitabine and Erlotinib with or without Oxaliplatin in Previously Untreated Advanced Pancreatic Cancer: A Randomized Phase II Trial
por: Lim, Sung Hee, et al.
Publicado: (2021)

Phase II study of ipilimumab and nivolumab in leptomeningeal carcinomatosis
por: Brastianos, Priscilla K., et al.
Publicado: (2021)

Cerebrospinal Fluid Profiles and Their Changes after Intraventricular Chemotherapy as Prognostic or Predictive Markers for Patients with Leptomeningeal Carcinomatosis
por: Kwon, Ji-Woong, et al.
Publicado: (2021)

Multiple Dural Tuberculomas Presenting as Leptomeningeal Carcinomatosis
por: Kocaeli, Hasan, et al.
Publicado: (2011)

Occult Breast Cancer Presenting as Leptomeningeal Carcinomatosis
por: McNally, Megan E., et al.
Publicado: (2012)

Leptomeningeal carcinomatosis in a patient with gallbladder carcinoma
por: Jose, Nisha, et al.
Publicado: (2017)

Leptomeningeal Carcinomatosis Presenting as Cauda Equina Syndrome
por: Patel, Bhagyadhan A., et al.
Publicado: (2017)

Symmetric Ventral Brainstem Lesion in Leptomeningeal Carcinomatosis
por: Maeda, Kengo, et al.
Publicado: (2018)

Leptomeningeal Carcinomatosis of Metastatic Primary Prostate Cancer
por: Stenberg, Daniel, et al.
Publicado: (2021)

Leptomeningeal carcinomatosis in small cell carcinoma of the prostate
por: Fukuta, Kyotaro, et al.
Publicado: (2022)

Prolonged Survival and Restored Useful Life by Early Induction of Intrathecal Chemotherapy in a Patient with Leptomeningeal Carcinomatosis from Ovarian Cancer
por: Takahara, Kento, et al.
Publicado: (2022)

LPTO-08. INTRATHECAL TRASTUZUMAB PLUS/MINUS IT TOPOTECAN FOR PATIENTS WITH HER2+ BREAST CANCER AND LEPTOMENINGEAL METASTASIS
por: Trevino, Christopher R, et al.
Publicado: (2019)

Phase II Clinical Trial of Genexol® (Paclitaxel) and Carboplatin for Patients with Advanced Non-small Cell Lung Cancer
por: Kim, Han Jo, et al.
Publicado: (2011)

Clinical Outcome of Gastric Cancer Patients with Bone Marrow Metastases
por: Kwon, Ji Yeon, et al.
Publicado: (2011)

Rapid symptomatic relief of HER2-positive gastric cancer leptomeningeal carcinomatosis with lapatinib, trastuzumab and capecitabine: a case report
por: Jiao, Xiao-Dong, et al.
Publicado: (2018)

Leptomeningeal carcinomatosis from gastric cancer: single institute retrospective analysis of 9 cases
por: Kim, Nam-Hee, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_4c3e0o83itje08u2e4tigj28ab